Resultado da Busca
Arvid Carlsson (Upsália, 25 de janeiro de 1923 - Gotemburgo, 29 de junho de 2018) foi um farmacologista sueco. [1] [2] Foi agraciado com o Nobel de Fisiologia ou Medicina de 2000. Polêmico, critica duramente a fluoretação da água potável, por considerar tal medida antiética e perigosa.
Arvid Carlsson (25 January 1923 – 29 June 2018) was a Swedish neuropharmacologist who is best known for his work with the neurotransmitter dopamine and its effects in Parkinson's disease. For his work on dopamine, Carlsson was awarded the Nobel Prize in Physiology or Medicine in 2000, together with Eric Kandel and Paul Greengard .
Arvid Carlsson was born in Uppsala, Sweden in 1923. Dr. Carlsson, a pharmacologist, is best known for his contributions on the neurotransmitter, dopamine, for which he won the Nobel Prize in 2000 for Medicine/Physiology. The co-recipients were Dr. Eric Kendel and Dr. Paul Greengard.
- Vikram K Yeragani, Manuel Tancer, Pratap Chokka, Glen B Baker
- 2010
Arvid Carlsson The Nobel Prize in Physiology or Medicine 2000 . Born: 25 January 1923, Uppsala, Sweden . Died: 29 June 2018, Gothenburg, Sweden . Affiliation at the time of the award: Göteborg University, Gothenburg, Sweden . Prize motivation: “for their discoveries concerning signal transduction in the nervous system” Prize share: 1/3
26 de out. de 2018 · Metrics. On 29 June 2018, neuropsychopharmacology and the American College of Neuropsychopharmacology (ACNP) lost one of its giants and true pioneers, Dr. Arvid Carlsson, MD, PhD, Swedish...
- Birte Glenthøj, H. Christian Fibiger
- 2019
25 de abr. de 2024 · Arvid Carlsson, Swedish pharmacologist who, along with Paul Greengard and Eric Kandel, was awarded the 2000 Nobel Prize for Physiology or Medicine for his research establishing dopamine as an important neurotransmitter in the brain. Carlsson’s work led to a treatment for Parkinson disease.
Arvid Carlsson was a Swedish pharmacologist who discovered dopamine as a neurotransmitter and its role in Parkinson's disease. He also contributed to the dopamine hypothesis of schizophrenia and the development of biological psychiatry and neurology in Scandinavia and beyond.
